BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32286195)

  • 1. Lung Cancer CT Screening and Lung-RADS in a Tuberculosis-endemic Country: The Korean Lung Cancer Screening Project (K-LUCAS).
    Kim H; Kim HY; Goo JM; Kim Y
    Radiology; 2020 Jul; 296(1):181-188. PubMed ID: 32286195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation and comparison of the Brock model and Lung-RADS for the baseline lung cancer CT screening using data from the Korean Lung Cancer Screening Project.
    Kim H; Kim HY; Goo JM; Kim Y
    Eur Radiol; 2021 Jun; 31(6):4004-4015. PubMed ID: 33241512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Ultrashort Echo Time Pulmonary MRI for Lung Nodule Detection and Lung-RADS Classification.
    Ohno Y; Takenaka D; Yoshikawa T; Yui M; Koyama H; Yamamoto K; Hamabuchi N; Shigemura C; Watanabe A; Ueda T; Ikeda H; Hattori H; Murayama K; Toyama H
    Radiology; 2022 Mar; 302(3):697-706. PubMed ID: 34846203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological Report of Pilot Study for the Korean Lung Cancer Screening (K-LUCAS) Project: Feasibility of Implementing Lung Imaging Reporting and Data System.
    Lee JW; Kim HY; Goo JM; Kim EY; Lee SJ; Kim TJ; Kim Y; Lim J
    Korean J Radiol; 2018; 19(4):803-808. PubMed ID: 29962887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program.
    Lee J; Lim J; Kim Y; Kim HY; Goo JM; Lee CT; Jang SH; Lee WC; Lee CW; An JY; Ko KD; Lee MK; Choi KS; Park B; Lee DH
    Cancer Res Treat; 2019 Oct; 51(4):1285-1294. PubMed ID: 30776882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assisted versus Manual Interpretation of Low-Dose CT Scans for Lung Cancer Screening: Impact on Lung-RADS Agreement.
    Jacobs C; Schreuder A; van Riel SJ; Scholten ET; Wittenberg R; Wille MMW; de Hoop B; Sprengers R; Mets OM; Geurts B; Prokop M; Schaefer-Prokop C; van Ginneken B
    Radiol Imaging Cancer; 2021 Sep; 3(5):e200160. PubMed ID: 34559005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of ACR Lung-RADS in a clinical CT lung screening program.
    McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
    J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
    Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
    Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort.
    Kessler A; Peng R; Mardakhaev E; Haramati LB; White CS
    Radiol Imaging Cancer; 2020 Mar; 2(2):e190021. PubMed ID: 33778703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
    Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
    JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.
    Lin Y; Liang LJ; Ding R; Prosper AE; Aberle DR; Hsu W
    JAMA Netw Open; 2023 May; 6(5):e2315250. PubMed ID: 37227725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Lung-RADS in Reducing False-Positive Results in a Diverse, Underserved, Urban Lung Cancer Screening Cohort.
    Kaminetzky M; Milch HS; Shmukler A; Kessler A; Peng R; Mardakhaev E; Bellin EY; Levsky JM; Haramati LB
    J Am Coll Radiol; 2019 Apr; 16(4 Pt A):419-426. PubMed ID: 30146484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
    Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
    JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
    Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
    Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
    Hammer MM; Hunsaker AR
    AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
    [No Abstract]   [Full Text] [Related]  

  • 18. Performance of Lung-RADS in different target populations: a systematic review and meta-analysis.
    Mao Y; Cai J; Heuvelmans MA; Vliegenthart R; Groen HJM; Oudkerk M; Vonder M; Dorrius MD; de Bock GH
    Eur Radiol; 2024 Mar; 34(3):1877-1892. PubMed ID: 37646809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
    Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
    J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.